Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study (Q40005099)

16 September 2017

title

Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study (English)

1 reference

16 September 2017

0 references

1 reference

0 references

0 references

0 references

Manal Gabril

1 reference

16 September 2017

William Dubinski

1 reference

16 September 2017

Youssef M Youssef

1 reference

16 September 2017

Hala Faragalla

1 reference

16 September 2017

Kalman Kovacs

1 reference

16 September 2017

Fabio Rotondo

1 reference

16 September 2017

Shereen Metias

1 reference

16 September 2017

Androu Arsanious

1 reference

16 September 2017

Anna Plotkin

1 reference

16 September 2017

Andrew H F Girgis

1 reference

16 September 2017

Catherine J Streutker

1 reference

16 September 2017

George M Yousef

1 reference

16 September 2017

publication date

31 October 2011

1 reference

16 September 2017

published in

Laboratory Investigation

1 reference

16 September 2017

1 reference

16 September 2017

1 reference

16 September 2017

page(s)

46-56

1 reference

Uncommon and recently described renal carcinomas

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Kidney cancer: identification of novel targets for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

The follow-up management of non-metastatic renal cell carcinoma: definition of a surveillance protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Significance of B7-H1 overexpression in kidney cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Protein expression profiles in renal cell carcinoma: staging, prognosis, and patient selection for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Exploring the pathogenesis of renal cell carcinoma: pathway and bioinformatics analysis of dysregulated genes and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Microvessel density in renal cell carcinoma: Lack of prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Clinical significance of tumor angiogenesis in patients with localized renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Histological quantitation of tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

What Is the Evidence That Tumors Are Angiogenesis Dependent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Sunitinib in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Tumor angiogenesis: past, present and the near future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Up-regulation of the redox mediators thioredoxin and apurinic/apyrimidinic excision (APE)/Ref-1 in hypoxic microregions of invasive cervical carcinomas, mapped using multispectral, wide-field fluorescence image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Quantitative image analysis of immunohistochemical stains using a CMYK color model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Heterogeneity and power in clinical biomarker studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

VHL and HIF signalling in renal cell carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Building on a foundation of VEGF and mTOR targeted agents in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

The combination of angiogenesis and blood vessel invasion as a prognostic indicator in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Primary study of neovasculature correlating with metastatic nasopharyngeal carcinoma using computer image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Effect of distributional heterogeneity on the analysis of tumor hypoxia based on carbonic anhydrase IX

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Evaluation of CD31 (PECAM-1) Expression Using Tissue Microarray in Patients with Renal Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Endoglin (CD105) expression in human renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

Metachronous Bilateral Renal Cell Carcinoma: Risk Assessment, Prognosis and Relevance of the Primary-Free Interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

7 January 2021

Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

7 January 2021

Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

7 January 2021

Microvessel quantitation and prognosis in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

7 January 2021

Inverse correlation of microvessel density with metastasis and prognosis in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

7 January 2021

PROGNOSTIC ROLE OF FUHRMAN GRADE AND VASCULAR ENDOTHELIAL GROWTH FACTOR IN pT1a CLEAR CELL CARCINOMA IN PARTIAL NEPHRECTOMY SPECIMENS

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

7 January 2021

Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

7 January 2021

Prognostic significance of microvessel count in low stage renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

7 January 2021

Angiogenesis in invasive breast carcinoma--a prospective study of tumour heterogeneity

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

7 January 2021

The relationship of vascularity of the primary tumour to lymph node metastases and to distant haematogenous spread in carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

7 January 2021

Computerized morphometric analysis of microvasculature in non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

7 January 2021

Tumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

7 January 2021

Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

7 January 2021

Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

7 January 2021

Prognostic significance of morphologic parameters in renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

7 January 2021

Microvessel density as a predictor of PSA recurrence after radical prostatectomy. A comparison of CD34 and CD31

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.153

7 January 2021

10.1038/LABINVEST.2011.153

Identifiers

DOI

1 reference

16 September 2017

1 reference